Servier, an independent international pharmaceutical group, is acquiring Day One Biopharmaceuticals for $21.50 per share in ...
Designing modular, automated vial fill-finish lines that balance high-output demands with small-batch precision in an Annex 1 ...
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds ...
Nicoya Lifesciences is launching FastHDX, a hydrogen-deuterium exchange mass spectrometry platform to measure protein ...
This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...
New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug discovery.
Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.
Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation ...
Coating Place Inc., a Wisconsin‑based CDMO, is marking its 50th anniversary with continued expansion efforts and new additions to its executive team.
The FDA has approved Johnson & Johnson’s TECVAYLI plus DARZALEX FASPRO for the treatment of adults with relapsed or refractory multiple myeloma.
Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.
XyloCor Therapeutics Inc. has appointed John Tucker as President and Chief Executive Officer (CEO), effective immediately.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results